Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  AJP - Renal Physiology

• Publication date

  2005-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPRENAL.00435.2004PMID 15870382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of oxidative stress in diabetic complications

  2007cited by this paper
• NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway.

  2004cited by this paper
• NF‐κB activation mechanism of 4‐hydroxyhexenal via NIK/IKK and p38 MAPK pathway

  2004cited by this paper
• Free radicals and aging.

  2004cited by this paper
• Gene expression in aging kidney and pituitary

  2004cited by this paper
• Galectin‐3/AGE‐receptor 3 knockout mice show accelerated AGE‐induced glomerular injury: evidence for a protective role of galectin‐3 as an AGE receptor

  2004cited by this paper
• The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration.

  2004cited by this paper
• Kidney function in older people: pathology, assessment and management.

  2003cited by this paper
• Involvement of Rel/NF-kappa B transcription factors in senescence.

  2003cited by this paper
• Molecular motors

  2003cited by this paper
• Determinants of glomerular hypofiltration in aging humans.

  2003cited by this paper
• Involvement of Rel/NF-κB transcription factors in senescence

  2003cited by this paper
• Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation.

  2003cited by this paper
• Role of galectin-3 in diabetic nephropathy.

  2003cited by this paper
• Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.

  2002cited by this paper
• The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins.

  2001influential reference
• Aging and proinflammatory cytokines

  2001cited by this paper
• Characterization of aging-associated up-regulation of constitutive nuclear factor-kappa B binding activity.

  2001cited by this paper
• Characterization of Aging-Associated Up-Regulation of Constitutive Nuclear Factor-κB Binding Activity

  2001cited by this paper
• 15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes

  2001cited by this paper
• Accelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice

  2001cited by this paper
• Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

  2001cited by this paper
• Protein glycation, diabetes, and aging.

  2001cited by this paper
• Transcription factor-kappa B (NF-kappa B) and renal disease.

  2001cited by this paper
• Oxidative damage to mitochondria and aging.

  2001cited by this paper
• CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products*

  2001cited by this paper
• Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

  2001cited by this paper
• Nitrosation and oxidation in the regulation of gene expression

  2000cited by this paper
• The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation.

  2000cited by this paper
• Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses.

  2000cited by this paper
• Oxidants, oxidative stress and the biology of ageing

  2000cited by this paper
• Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine.

  2000cited by this paper
• The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.

  2000cited by this paper
• Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

  2000cited by this paper
• Why do we age?

  2000cited by this paper
• An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

  2000cited by this paper
• Induction of transcriptional activity of AP-1 and NF-kappaB in the gastric mucosa during aging.

  2000cited by this paper
• Role of galectin-3 as a receptor for advanced glycosylation end products.

  2000cited by this paper
• Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation.

  1999cited by this paper
• The p66shc adaptor protein controls oxidative stress response and life span in mammals

  1999cited by this paper
• Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

  1999cited by this paper
• N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression*

  1999cited by this paper
• Age-dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parenteral administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of HNE-protein adducts in oxidative stress and carcinogenesis.

  1999cited by this paper
• Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

  1998cited by this paper
• Age-related increase in expression of TGF-beta1 in the rat kidney: relationship to morphologic changes.

  1998cited by this paper
• The aging kidney: insights from experimental studies.

  1998cited by this paper
• Regulation of cellular adhesion to extracellular matrix proteins by galectin-3.

  1998influential reference
• Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells

  1997cited by this paper
• Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress*

  1997cited by this paper
• Age-related changes in the regulation of transcription factor NF-κB in rat brain

  1997cited by this paper
• Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells.

  1997cited by this paper
• Age-related changes in the regulation of transcription factor NF-kappa B in rat brain.

  1997cited by this paper
• Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

  1997cited by this paper
• Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B.

  1996cited by this paper
• Protein glycation in the kidney: role in diabetes and aging.

  1996cited by this paper
• Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

  1996cited by this paper
• Expression of galectin-3 modulates T-cell growth and apoptosis.

  1996cited by this paper
• Advanced Glycation End Products and Their Recognition by Macrophage and Macrophage-Derived Cells

  1996cited by this paper
• Identification of galectin-3 as a factor in pre-mRNA splicing.

  1995cited by this paper
• Aging-associated changes in renal extracellular matrix.

  1995cited by this paper
• Role of advanced glycation end-products (AGE) in late diabetic complications.

  1995cited by this paper
• Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor Complex

  1995influential reference
• Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion.

  1995cited by this paper
• Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

  1994influential reference
• Epsilon BP, a beta-galactoside-binding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells.

  1993cited by this paper
• Glomerular number and size in relation to age, kidney weight, and body surface in normal man

  1992cited by this paper
• Free radicals and aging.

  1968cited by this paper
• Insight Review Articles

  year unknowncited by this paper

• Protective Role of p66Shc Deletion in Physiological Renal Aging: Effects on G Protein-Coupled Receptor 124 Expression and Associated Cellular Senescence

  2025cites this paper
• The Possible Effects of Galectin-3 on Mechanisms of Renal and Hepatocellular Injury Induced by Intravascular Hemolysis

  2024cites this paper
• Unraveling the role of galectin-3 in cardiac pathology and physiology

  2023cites this paper
• Targeting Scavenger Receptors in Inflammatory Disorders and Oxidative Stress

  2022cites this paper
• Genetic Deletion of Galectin-3 Exacerbates Age-Related Myocardial Hypertrophy and Fibrosis in Mice.

  2022cites this paper
• Galectin-3 protects auditory function in female mice.

  2022cites this paper
• Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.

  2020cites this paper
• Glycobiology of developing chicken kidney: profiling the galectin family and selected β-galactosides.

  2020cites this paper
• Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive Treatment

  2017cites this paper
• Chapter 5 Galectin-3 and Post-Myocardial Infarction Cardiac Remodeling

  2017cites this paper
• Angiotensin II Type 1 Receptor‐Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin

  2017cites this paper
• Role of galectin-3 in autoimmune and non-autoimmune nephropathies.

  2017cites this paper
• Inflammation and insulin resistance: New targets encourage new thinking

  2017cites this paper
• Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease

  2016cites this paper
• Galectin-3, Cardiac Function, and Fibrosis.

  2016cites this paper
• Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade

  2015cites this paper
• Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy.

  2015cites this paper
• Galectin-3: an emerging all-out player in metabolic disorders and their complications.

  2015influential citation
• Galectin-3 in autoimmunity and autoimmune diseases

  2015cites this paper
• Galectin-3 In Obesity And Type 2 Diabetes

  2015cites this paper
• GALECTIN3 IN OBESITY AND TYPE 2 DIABETES

  2015cites this paper
• Galectin-3 and post-myocardial infarction cardiac remodeling.

  2015cites this paper
• Galectin-3 in fibrosis and heart failure

  2014cites this paper
• Galectin-3 in diabetic patients

  2014cites this paper
• Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology

  2013cites this paper
• Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice

  2013cites this paper
• Cell cycle arrest in a model of colistin nephrotoxicity.

  2013cites this paper
• Arginase II: Atherogenesis Beyond Enzyme Activity

  2013cites this paper
• Adipose tissue‐specific modulation of galectin expression in lean and obese mice: Evidence for regulatory function

  2013cites this paper
• The purinergic 2X7 receptor participates in renal inflammation and injury induced by high‐fat diet: possible role of NLRP3 inflammasome activation

  2013cites this paper
• Protein glycation during aging and in cardiovascular disease.

  2013cites this paper
• CALL FOR PAPERS Understanding the Mechanisms of Disease Using Biomarkers Cell cycle arrest in a model of colistin nephrotoxicity

  2013cites this paper
• Galectin-3: Forms, Functions, and Clinical Manifestations

  2012cites this paper
• [Galectin 3--a new biomarker for diagnostics and outcome of chronic heart failure].

  2012cites this paper
• [Protein glycation as a pathological mechanism in diabetes].

  2012cites this paper
• Galectins in acute and chronic inflammation

  2012cites this paper
• Galectin‐3 is a new MerTK‐specific eat‐me signal

  2012cites this paper
• Proteinglykierung als pathophysiologischer Mechanismus bei Diabetes

  2012cites this paper
• Diabetic Nephropathy: Current and Novel Therapeutic Approaches to Prevent Its Development and Progression

  2012cites this paper
• D‐carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation

  2012cites this paper
• Galectins in immune and inflammatory diseases: Insights from experiments with galectin deficient mice

  2012cites this paper
• Dietary factors and low-grade inflammation in relation to overweight and obesity

  2011cites this paper
• Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.

  2011cites this paper
• Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis.

  2011cites this paper
• Galectins: regulators of acute and chronic inflammation

  2010cites this paper
• Galectin-3 in Cardiac Remodeling and Heart Failure

  2010cites this paper
• Regulation of matrix synthesis, remodeling and accumulation in glomerulosclerosis.

  2009cites this paper
• Advanced lipoxidation end‐products mediate lipid‐induced glomerular injury: role of receptor‐mediated mechanisms

  2009cites this paper
• Advanced glycation end products ( AGEs ) in diabetes

  2009cites this paper
• Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets.

  2009cites this paper
• Accelerated Lipid-Induced Atherogenesis in Galectin-3–Deficient Mice: Role of Lipoxidation via Receptor-Mediated Mechanisms

  2009cites this paper
• Effects of dihydrotestosterone on gene expression in mammary gland.

  2008cites this paper
• Advanced glycation end products: mogelijke verklaring voor ouderdomsziekten bij mens en dier?

  2008cites this paper
• Of cardiovascular illness and diversity of biological response.

  2008cites this paper
• Role of AGEs in diabetic nephropathy.

  2008cites this paper
• Loss of galectin-3 impairs membrane polarisation of mouse enterocytes in vivo

  2008cites this paper
• Action des hormones stéroïdiennes sur le transcriptome de la glande mammaire chez la souris

  2008cites this paper
• Of mice and men: Sparse statistical modeling in cardiovascular genomics

  2007cites this paper
• OF MICE AND MEN: SPARSE STATISTICAL MODELING IN CARDIOVASCULAR GENOMICS 1

  2007cites this paper
• Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease

  2006cites this paper
• Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease.

  2006cites this paper
• Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3.

  2006cites this paper
• Deletion of p66Shc Longevity Gene Protects Against Experimental Diabetic Glomerulopathy by Preventing Diabetes-Induced Oxidative Stress

  2006cites this paper